US 10973861
Compositions and methods
granted A61KA61K2035/115A61K35/741
Quick answer
US patent 10973861 (Compositions and methods) held by Seres Therapeutics, Inc. expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Seres Therapeutics, Inc.
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2035/115, A61K35/741, A61K35/742, A61K35/744